QVOLIRA
Live / Applied — First extension granted (statement of use) (as of 17 Dec 2025)
What this means for you
Not registered yet, but its 06 May 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99170896
- Mark type
- Stylized text
- Filed
- 06 May 2025
- Published for opposition
- 21 Oct 2025
- Attorney of record
- Michael A. Geller
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treatment of dermatological conditions, diseases, and disorders
Owner
- Palvella Therapeutics, Inc., Wayne, PA, US
- Palvella Therapeutics, Inc., Wayne, PA, US
Prosecution history
- 17 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Dec 2025 — SOU EXTENSION 1 GRANTED
- 17 Dec 2025 — SOU EXTENSION 1 FILED
- 17 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 16 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Oct 2025 — PUBLISHED FOR OPPOSITION
- 15 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Sept 2025 — ASSIGNED TO EXAMINER
- 06 May 2025 — APPLICATION FILING RECEIPT MAILED
- 06 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 May 2025 — NEW APPLICATION ENTERED